CN105617161A - 治疗痛风的中药组合物 - Google Patents
治疗痛风的中药组合物 Download PDFInfo
- Publication number
- CN105617161A CN105617161A CN201610091392.6A CN201610091392A CN105617161A CN 105617161 A CN105617161 A CN 105617161A CN 201610091392 A CN201610091392 A CN 201610091392A CN 105617161 A CN105617161 A CN 105617161A
- Authority
- CN
- China
- Prior art keywords
- herba
- rhizoma
- chinese medicine
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 201000005569 Gout Diseases 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000255791 Bombyx Species 0.000 claims abstract description 8
- 241000237636 Pheretima Species 0.000 claims abstract description 8
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 8
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 8
- 241000018646 Pinus brutia Species 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 238000002791 soaking Methods 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 27
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000017008 Dioscorea nipponica Nutrition 0.000 abstract 1
- 241000908494 Dioscorea nipponica Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 35
- 230000036407 pain Effects 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 19
- 208000006820 Arthralgia Diseases 0.000 description 17
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 17
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 229940116269 uric acid Drugs 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000025747 Rheumatic disease Diseases 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 230000000552 rheumatic effect Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010062575 Muscle contracture Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 208000006111 contracture Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 208000001647 Renal Insufficiency Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 201000006370 kidney failure Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 230000002522 swelling effect Effects 0.000 description 3
- 210000001171 synovial bursa Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- XDKLKFULWJYRCB-UHFFFAOYSA-N 7,9-dihydro-3h-purine-2,6,8-trione;sodium Chemical compound [Na].N1C(=O)NC(=O)C2=C1NC(=O)N2 XDKLKFULWJYRCB-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016173 Fall Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022822 Intravascular haemolysis Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027423 Metabolic alkalosis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- CZCIKBSVHDNIDH-NSHDSACASA-N N(alpha)-methyl-L-tryptophan Chemical compound C1=CC=C2C(C[C@H]([NH2+]C)C([O-])=O)=CNC2=C1 CZCIKBSVHDNIDH-NSHDSACASA-N 0.000 description 1
- CZCIKBSVHDNIDH-UHFFFAOYSA-N Nalpha-methyl-DL-tryptophan Natural products C1=CC=C2C(CC(NC)C(O)=O)=CNC2=C1 CZCIKBSVHDNIDH-UHFFFAOYSA-N 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010048873 Traumatic arthritis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000002849 chondrocalcinosis Diseases 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001226 toe joint Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种药物配方领域,具体地说是一种治疗痛风的中药组合物,其特征在于由如下重量百分比的原料药制成:油松节8-11%;肿节风7-9%;鸡骨草7-9%;鸭跖草7-10%;豨莶草2-5%;伸筋草2-5%;连钱草6-9%;两面针2-4%;狗脊3-5%;大血藤3-5%;穿山龙3-5%;络石藤2-4%;龟甲4-7%;珠子参2-4%;秦艽2-3%;土茯苓6-9%;地龙2-4%;蜘蛛香1-2%;薤白2-3%;僵蚕2-3%;苏木2-4%;海风藤2-4%,将上述原料药用水浸泡,煎熬后去渣得滤液。本发明成本低、治疗痛风疗效高、无毒副作用、不复发。
Description
技术领域
本发明涉及一种中成药制剂,具体地说是一种治疗痛风的中药组合物。
背景技术
众所周知,痛风是一种由于嘌呤生物合成代谢增加,尿酸产生过多或因尿酸排泄不良而致血中尿酸升高,尿酸盐结晶沉淀在关节滑膜、滑囊、软骨及其他组织中引起的反复发作性疾病。本病以关节液和痛风石中可以找到有双折光性的单水尿酸钠结晶为特点。其临床表现为高尿酸血症及尿酸盐结晶、沉淀所致的特征性急性关节炎、痛风石、间质性肾炎,严重者见关节畸形及功能障碍,常伴尿酸性尿路结石,多见于体型肥胖的中老年男性和绝经后妇女(占5%)。痛风是百痛之首,一旦发作痛彻心扉,受累关节红、肿、疼痛、僵硬。典型发作常见于深夜因关节痛而惊醒,疼痛进行性加剧,在12小时左右达高峰,呈撕裂样、刀割样或咬噬样,难以忍受,受累关节红肿疼痛和功能受限。部分患者可有发热、寒战、头痛、心悸和恶心等全身症状,可伴白细胞计数升高,红细胞沉降率增快和C反应蛋白增高等,重者可出现关节残疾和肾功能不全等。临床治疗主要对症处理:碱性药物碱化尿液、秋水仙碱、非甾体抗炎药、糖皮质激素及别嘌呤醇等。西药不良反应重,恶心呕吐、厌食、腹胀和水样便,长期大量服用碱性药物可致代谢性碱中毒,且可因钠负荷过高引起水肿。激素类药物停药后易引起“反跳”症状。该类药物严重不良反应还可以发生骨髓抑制、肾衰竭、弥散性血管内溶血、肝坏死等。该病停药后易复发,成为临床难点。
发明内容
本发明所要解决的技术问题是为了克服现有技术的不足,提供一种治疗痛风的中药组合物,成本低、治疗痛风疗效高、无毒副作用、不复发。具有行气活血、解毒散瘀、通络除痹、清热除湿、软坚散结、祛风胜石、滋肾通关、消肿止痛等功效,可以有效修复骨滑囊,减少创伤,疏通关节部位水肿淤积,防止尿酸在关节部位的堆积而破坏关节及筋腱组织,增强关节循环,提高血液在关节的血流量,防止尿酸沉积,痛风石变软变小,并被大量溶解,通过小便排出体外,消除关节肿胀、麻木、僵直、屈伸不利等症状,对原发性和继发性痛风均有效。
本发明解决上述技术问题采用的技术方案是:一种治疗痛风的中药组合物,其特征在于由如下重量百分比的原料药制成:油松节8-11%;肿节风7-9%;鸡骨草7-9%;鸭跖草7-10%;豨莶草2-5%;伸筋草2-5%;连钱草6-9%;两面针2-4%;狗脊3-5%;大血藤3-5%;穿山龙3-5%;络石藤2-4%;龟甲4-7%;珠子参2-4%;秦艽2-3%;土茯苓6-9%;地龙2-4%;蜘蛛香1-2%;薤白2-3%;僵蚕2-3%;苏木2-4%;海风藤2-4%,将上述原料药用水浸泡,煎熬后去渣得滤液。
本发明的有益效果是,成本低、治疗痛风疗效高、无毒副作用、不复发。具有行气活血、解毒散瘀、通络除痹、清热除湿、软坚散结、祛风胜石、滋肾通关、消肿止痛等功效,可以有效修复骨滑囊,减少创伤,疏通关节部位水肿淤积,防止尿酸在关节部位的堆积而破坏关节及筋腱组织,增强关节循环,提高血液在关节的血流量,防止尿酸沉积,痛风石变软变小,并被大量溶解,通过小便排出体外,消除关节肿胀、麻木、僵直、屈伸不利等症状,对原发性和继发性痛风均有效。
具体实施方式
下面结合实施例对本发明作进一步的描述:
实施例1:
采用油松节、肿节风、鸡骨草、鸭跖草、豨莶草、伸筋草、连钱草、两面针、狗脊、大血藤、穿山龙、络石藤、龟甲、珠子参、秦艽、土茯苓、地龙、蜘蛛香、薤白、僵蚕、苏木、海风藤为原料药制备而成。其组分(重量%)每付为油松节9.9、肿节风8.4、鸡骨草8.5、鸭跖草8.7、豨莶草3.6、伸筋草3.8、连钱草7.6、两面针2.1、狗脊3.5、大血藤3.7、穿山龙3.8、络石藤3.5、龟甲5.9、珠子参2.5、秦艽2.3、土茯苓7.5、地龙2.3、蜘蛛香1.9、薤白2.5、僵蚕2.4、苏木2.7、海风藤2.9。取上述22味中草药总重量373克,龟甲单包先煎,余21味中草药加水至900-1100ml,加冷水漫过药面,在室温下浸泡2-3小时。龟甲先煎煮沸30分钟后,再将浸泡的余21味中草药连同浸泡液一起倒入同煎,用武火煮沸文火煎熬至80-90分钟,去渣得滤液200ml,药渣再加水300ml左右,煎熬30-40分钟左右,去渣得滤液100ml左右,共得300ml左右药汁,即制得松节骨汤,装入无菌玻璃瓶内,摇匀,密封瓶盖备用。每日一剂分3次口服,每次空腹温服100ml左右。
本发明主药油松节化学成分含挥发油,油中主要为α-及β蒎烯,占90%以上,另含少量左旋-莰烯、二戌烯等,此外尚含树脂。性味苦、辛、温,入肝、肾经。具有祛风除湿,通络止痛功效,用于风寒湿痹、历节风痛、转筋挛急、跌打伤痛。肿节风性味苦、辛、平,归心、肝经。具有清热凉血、活血清斑、祛风通络功效,用于血热发斑发疹、风湿痹痛、跌打损伤。鸡骨草根叶含甘草甜素,种子含相思子碱、胆碱,此外,可能含一种甾醇类化合物。具有利湿退黄、清热解毒、疏肝止痛功效,用于湿热黄疸、胁肋不舒、胃脘胀痛、乳痛肿痛。鸭跖草性味甘、淡、寒,归肺、胃、小肠经。具有清热泻火、解毒、利水消肿功效。用于感冒发热、热病烦渴、咽喉肿痛、水肿尿少、热淋涩痛、痈肿疔毒。豨莶草性味辛、苦、寒,归肝、肾经。具有祛风湿、利关节、解毒功效,用于风湿痹痛、筋骨无力、腰膝酸软、四肢麻痹、半身不遂、风疹湿疮。伸筋草性味微苦、辛、温,归肝、脾、肾经。具有祛风除湿、舒筋活络功效,用于关节酸痛、屈伸不利。连钱草性味辛、微苦、微寒,归肝、肾、膀胱经。具有利湿通淋、清热解毒、散瘀消肿功效,用于热淋、石淋、湿热黄疸、疮痈肿痛、跌打损伤。两面针性味苦、辛、平、有小毒,归肝、胃经。具有活血化瘀、行气止痛、祛风通络、解毒消肿功效,用于跌打损伤、胃痛、牙痛、风湿痹痛、毒蛇咬伤等。狗脊性味苦、甘、温,归肝、肾经。具有祛风湿、补肝肾、强腰膝功效,用于风湿痹痛、腰膝酸软、下肢无力。大血藤性味苦、平,归大肠、肝经。具有清热解毒、活血祛风、止痛功效,用于肠痛腹痛、热毒疮疡、经闭、痛经、跌扑肿痛、风湿痹痛。穿山龙性味甘、苦、温,归肝、肾、肺经。具有祛风除湿、舒筋通络、活血止痛、止咳平喘功效,用于风湿痹痛、关节肿胀、疼痛麻木、跌扑损伤、闪腰岔气、咳嗽气喘。络石藤性味苦、微寒,归心、肝、肾经,具有祛风通络、凉血消肿功效,用于风湿热痹、筋脉拘挛、腰膝酸痛、喉痹、痈肿、跌扑损伤。龟甲性味咸、甘、微寒,归肝、肾、心经。具有滋阴潜阳、益肾强骨、养血补心、固经止崩功效,用于阴虚潮热、骨蒸盗汗、头晕目眩、虚风内动、筋骨瘘软、心虚健忘、崩漏经多。珠子参性味苦、甘、微寒,归肝、肺、胃经。具有补肺养阴、祛瘀止痛、止血功效,用于气阴两虚、烦热口渴、虚劳咳嗽、跌扑损伤、关节痹痛、咳血等。秦艽性味辛、苦、平,归胃、肝、胆经。具有祛风湿、清湿热、止痹痛、退虚热功效,用于风湿痹痛、中风、半身不遂、筋脉拘挛、骨节酸痛、湿热黄疸、骨蒸热潮等。土茯苓性味甘、淡平,归肝、胃经,具有解毒、除湿、通利关节功效。用于梅毒及汞中毒所致的肢体拘挛、筋骨疼痛、湿热淋浊、带下、痈肿、瘰疬、疥癣。地龙性味咸、寒,归肝、脾、膀胱经,具有清热定惊、通络、平喘、利尿功效,用于高热神昏、惊痛抽搐、关节痹痛、肢体麻木、半身不遂、肺热喘咳、水肿尿少。蜘蛛香性味微苦、辛、温,归心、脾、胃经。具有理气止痛、消食止泻、祛风除湿、镇惊安神功效,用于风湿痹痛、腰膝酸软等。薤白性味辛、苦、温,归心、肺、胃、大肠经。具有通阳散结、行气导滞功效,用于胸痹心痛、脘腹痞满胀痛、泻痢后重。僵蚕性味咸、辛、平,归肺、肝、胃经,具有息风止痉、祛风止痛、化痰散结功效,用于肝风夹痰、惊痛抽搐、破伤风、风热头痛等。苏木性味甘、咸、平,归心、肝、脾经。具有活血祛瘀、消肿止痛功效。用于跌打掐伤、骨折筋伤、瘀滞肿痛、经闭痛经、产后瘀阻、胸腹刺痛、痈疽肿痛。海风藤性味辛、苦、微温,归肝经。具有祛风湿、通经络、止痹痛功效,用于风寒、湿痹、肢节疼痛、筋脉拘挛、屈伸不利。22味中草药巧妙组方、科学配伍、药物相须、相使配伍,可以起到协同作用,能提高药效,相畏、相杀配伍可以减轻或消除毒副作用。诸药合用,共秦清热除湿、利关节消肿止痛之功效,有效激活肾小管上皮细胞,修复肾小管功能,尿酸被大量排出体外,痛风石消失,肾脏自主排酸功能恢复,从根本上解决了痛风久治不愈、反复发作的难题。
实施例2:
其组分(重量%)每付为油松节9.9、肿节风8.4、鸡骨草8.5、鸭跖草8.7、豨莶草3.6、伸筋草3.8、连钱草7.6、两面针2.1、狗脊3.5、大血藤3.7、穿山龙3.8、络石藤3.5、龟甲5.9、珠子参2.5、秦艽2.3、土茯苓7.5、地龙2.3、蜘蛛香1.9、薤白2.5、僵蚕2.4、苏木2.7、海风藤2.9。取上述22味中草药总重量373克,龟甲单包先煎,余21味中草药加水至900-1100ml,加冷水漫过药面,在室温下浸泡2-3小时。龟甲先煎煮沸30分钟后,再将浸泡的余21味中草药连同浸泡液一起倒入同煎,用武火煮沸文火煎熬至80-90分钟,去渣得滤液200ml,药渣再加水300ml左右,煎熬30-40分钟左右,去渣得滤液100ml左右,共得300ml左右药汁,即制得松节骨汤,装入无菌玻璃瓶内,摇匀,密封瓶盖备用。每日一剂分3次口服,每次空腹温服100ml左右。
实施例3:
其组分(重量%)每付为油松节9.4、肿节风8.1、鸡骨草8.1、鸭跖草8.1、豨莶草3.2、伸筋草3.2、连钱草8.1、两面针2.7、狗脊3.2、大血藤4.1、穿山龙4.1、络石藤3.2、龟甲6.2、珠子参2.3、秦艽2.6、土茯苓8.1、地龙2.7、蜘蛛香1.6、薤白2.7、僵蚕2.7、苏木2.4、海风藤2.4。其加工工艺与实施例1相同。
下面结合临床试验对本发明作进一步、详细地描述:
1.病例选择:选择2009年8月至2013年10月来我院诊治,诊断为痛风患者69例,男66例、女3例;年龄43至71岁;病程6天至1年7个月。所选患者均有持续性高尿酸血症史,男性和绝经后女性血尿酸>420umol/L,绝经前女性>350umol/L,多在午夜或清晨突然起病,多呈剧痛,数小时内出现受累关节红、肿、热、痛和功能障碍。单侧踇趾及第一跖趾关节最常见,其余依次为踝、膝、腕、指、肘等关节。典型发作常于深夜因关节痛而惊醒,疼痛进行性加剧,呈撕裂样、刀割样或咬噬样,难以忍受,受累关节红肿疼痛和功能障碍。部分患者可有发热、寒战、头痛、心悸和恶心等全身症状,可伴白细胞计数升高、红细胞沉降率增快和C反应蛋白增高等,重者可出现关节残疾和肾功能不全等。关节液穿刺或痛风石活检证实为尿酸盐结晶可做出诊断。X线检查、CT或MRI扫描对明确诊断具有一定价值。所有患者均排除类风湿性、化脓性、创伤性关节炎,强直性脊柱炎早期外周关节炎,假性痛风、肾石病等。
2.诊断标准:参照中华人民共和国中医药行业标准《中医病证诊断疗效标准》(ZY/T001.1--94)。中医诊断要点:(1)多以多个趾指关节卒然红肿疼痛,逐渐疼痛剧烈如虎咬、昼轻夜甚、反复发作,可伴发热、头痛等症。(2)多见于中老年男性,可有痛风家族史,常因劳累、暴饮暴食、吃高嘌呤食品、饮酒及外感风寒等诱发。(3)初起可单关节发病,以第一跖趾关节多见。继以足踝、跟、手指和其他小关节,出现红、肿、热、痛,甚则关节腔可有渗液,反复发作后,可伴有关节四周及耳廓,耳轮及趾、指骨间出现“块瘰”(痛风石)。西医诊断标准:参照1977年美国风湿病学会(ACR)的分类标准或1985年Holmes标准。
3.治疗方法:实施例1松节骨汤每日1剂分3次口服,每次空腹温服100ml左右。期间注意低嘌呤饮食,忌烟酒等,并持之以恒。治疗两个月,应用至临床症状体征消失,再巩固疗效应用10天。
4.疗效评价标准:
显效:关节红肿热痛症状消失,僵硬开始驱散,关节逐步伸屈自如,尿酸钠盐微结晶迅速降低,关节内痛风石表面溶解并逐步消失,关节各脏器功能恢复正常,血尿酸降至正常,二年内不复发。
有效:关节红肿热痛症状明显减轻,僵硬明显好转,关节可以伸屈,关节及各脏器功能明显改善,血尿酸下降至正常高值,一年内偶有复发。
无效:关节红肿热痛症状不缓解,关节持续僵硬,伸屈不利,功能受限,血尿酸居高不下,有时短期好转但反复发作,各脏器功能无改善,有时甚至病情加重。
5.治疗结果:使用本发明69例痛风患者,应用疗效评价标准进行治疗效果评价:显效3例,占53.6%;有效26例,占37.7%;无效6例,占8.7%。总有效率为91.3%(显效加有效为总有效率)。
注:我们观察到:无效6例中,均为原发性痛风,体重均超标、肥胖,血脂、血糖、血压高,动脉硬化或冠心病,血尿酸持续增高多年不降。
Claims (1)
1.一种治疗痛风的中药组合物,其特征在于由如下重量百分比的原料药制成:油松节8-11%;肿节风7-9%;鸡骨草7-9%;鸭跖草7-10%;豨莶草2-5%;伸筋草2-5%;连钱草6-9%;两面针2-4%;狗脊3-5%;大血藤3-5%;穿山龙3-5%;络石藤2-4%;龟甲4-7%;珠子参2-4%;秦艽2-3%;土茯苓6-9%;地龙2-4%;蜘蛛香1-2%;薤白2-3%;僵蚕2-3%;苏木2-4%;海风藤2-4%,将上述原料药用水浸泡,煎熬后去渣得滤液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610091392.6A CN105617161A (zh) | 2016-01-28 | 2016-01-28 | 治疗痛风的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610091392.6A CN105617161A (zh) | 2016-01-28 | 2016-01-28 | 治疗痛风的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105617161A true CN105617161A (zh) | 2016-06-01 |
Family
ID=56032766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610091392.6A Pending CN105617161A (zh) | 2016-01-28 | 2016-01-28 | 治疗痛风的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105617161A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481469A (zh) * | 2018-08-03 | 2019-03-19 | 湖北老中醫制药有限责任公司 | 一种龟甲胶治疗痛风的药物及龟甲胶在制备治疗痛风药物中的应用 |
-
2016
- 2016-01-28 CN CN201610091392.6A patent/CN105617161A/zh active Pending
Non-Patent Citations (1)
Title |
---|
高新彦: "《痛风病中医诊疗经验集》", 30 April 2012, 西安交通大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481469A (zh) * | 2018-08-03 | 2019-03-19 | 湖北老中醫制药有限责任公司 | 一种龟甲胶治疗痛风的药物及龟甲胶在制备治疗痛风药物中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103393827B (zh) | 治疗痛风的药酒 | |
CN102526327B (zh) | 一种治疗风湿骨病的复合中草药及其制作方法 | |
CN104825938A (zh) | 一种治疗痛风的中药组合物 | |
CN101284114A (zh) | 治疗风湿和类风湿疾病的药物 | |
CN101011544A (zh) | 痛风速康颗粒(胶囊)及其制作工艺 | |
CN106266463B (zh) | 一种用于治疗高尿酸血症的中药组合物及其应用 | |
CN105288371A (zh) | 一种治疗痛风的中药组合物 | |
CN108837106A (zh) | 一种治疗痛风病的药物及制备方法 | |
CN103263601B (zh) | 一种加速骨折手术后愈合速度的中药制剂及制备方法 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN107468768A (zh) | 一种羌药组合物及其用途 | |
CN103961587A (zh) | 一种治疗造影剂肾病的中药制剂及制备方法 | |
CN104352901A (zh) | 一种治疗痛风的中药 | |
CN109820943B (zh) | 一种治疗痛风的壮药制剂及其制备方法 | |
CN105287748A (zh) | 治疗高尿酸血症的中药制剂及其制备方法 | |
CN105617161A (zh) | 治疗痛风的中药组合物 | |
CN101073648A (zh) | 老年性便秘的治疗方法 | |
CN1136005C (zh) | 治疗风湿性骨关节病的中药制剂 | |
CN102485270A (zh) | 一种治疗痛风的中药制剂及其制备方法 | |
CN101732507A (zh) | 一种治疗痛风病的泡脚中药方剂及制备方法 | |
CN106362066A (zh) | 一种治疗风湿类风湿性疾病的药酒及其制备方法 | |
CN104127636A (zh) | 一种治疗痛风病的中药组合物 | |
CN104257779B (zh) | 一种抗痛风的药物组合物及其制备方法 | |
CN103638232B (zh) | 一种治疗风湿病的中药组合物 | |
CN102000305B (zh) | 一种治疗痛风的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160601 |